Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
A Pilot, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Preliminary Clinical Activity and Immunogenicity of Multiple Doses of LEA29Y and CTLA4Ig Administered Intravenously to Subjects With Rheumatoid Arthritis A Pilot, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Pr ...
Rheumatoid Arthritis
Drug: Belatacept;Drug: Abatacept
Bristol-Myers Squibb
NULL
Completed
18 Years
65 Years
Both
210
Phase 1/Phase 2
United States;Belgium;Canada;France;Germany;Ireland;Netherlands;Switzerland;United Kingdom